Pou Anna M
Department of Otolaryngology, University of Texas Medical Branch, Room 7.104, John Sealy Annex, Galveston, TX 77555-0521, USA.
Curr Opin Otolaryngol Head Neck Surg. 2003 Aug;11(4):240-4. doi: 10.1097/00020840-200308000-00004.
Craniofacial reconstruction may be limited by the paucity of autologous materials available and donor site morbidity. Recent advances in the development of biomaterials have given the reconstructive surgeon new options for restoring form and function. There are now biomaterials (second generation) that can elicit a controlled action and reaction to the surrounding tissue environment (bioactive), and those that can exhibit a controlled chemical breakdown and resorption, with ultimate replacement by regenerating tissue (resorbable). Third-generation biomaterials are being designed to stimulate regeneration of living tissues using tissue engineering and in situ tissue regeneration methods. These techniques will lead to limitless possibilities for tissue regeneration and repair. At present, biomaterials that may find future use in craniofacial reconstruction include newly developed bone and skin substitutes and soft-tissue fillers.
颅面重建可能会受到可用自体材料匮乏以及供区并发症的限制。生物材料开发方面的最新进展为重建外科医生提供了恢复形态和功能的新选择。现在有一些生物材料(第二代)能够对周围组织环境产生可控的作用和反应(生物活性),还有一些能够呈现可控的化学分解和吸收,并最终被再生组织替代(可吸收)。第三代生物材料正被设计用于利用组织工程和原位组织再生方法刺激活组织的再生。这些技术将为组织再生和修复带来无限可能。目前,未来可能用于颅面重建的生物材料包括新开发的骨和皮肤替代物以及软组织填充剂。